MICROVASCULAR THERAPEUTICS LLC
Tucson, AZ · Medtech · Private
MVT-100, an electrostatically neutral microbubble contrast agent for ultrasound imaging with room-temperature stability
- Grants
- $6.1M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 0 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Development of New Improved Perflutren Ultrasound Contrast Agent | $1,229,385 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Development of New Improved Perflutren Ultrasound Contrast Agent | $1,613,934 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of New Improved Perflutren Ultrasound Contrast Agent | $384,549 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Ultrasound-Stimulated Phase-Change Contrast Agents for Sonothrombolysis. | $378,190 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Ultrasound-Stimulated Phase-Change Contrast Agents for Sonothrombolysis. | $378,190 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted ultrasound contrast agents for the disruption of Alzheimer's plaques. | $395,506 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted ultrasound contrast agents for the disruption of Alzheimer's plaques. | $411,171 | |
| Federal grant | Department of Health and Human Services · Phase II · MVT-100 Manufacturing and Commercialization. | $498,230 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Selectivity and Efficacy of CD90-targeted Phase Shift Microbubbles for HIFU-mediated Non-Thermal Ablation of Brain Tumors. | $397,597 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Selectivity and Efficacy of CD90-targeted Phase Shift Microbubbles for HIFU-mediated Non-Thermal Ablation of Brain Tumors. | $397,597 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2214 | VANISH THERAPEUTICS INC | — | — |
| 2215 | CICERODX, INC. | — | — |
| 2216 | Elk Valley Enterprises, Inc. | — | — |
| 2217 | MICROVASCULAR THERAPEUTICS LLC | — | — |
| 2218 | TRULY TECHNOLOGIES LLC | — | — |
| 2219 | BLOTTING INNOVATIONS, INC | — | — |
| 2220 | CELESTIAL ONCOLOGY INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Systems and Methods for Filling Vials with Gasesapplication
- Compositions And Methods Of Detecting And Treating Thrombosis And Vascular Plaquesapplication
- Compositions And Methods Of Detecting And Treating Thrombosis And Vascular Plaquesapplication
- Alkylated Nucleosides, And Compositions And Methods Thereof For Nucleic Acid Deliveryapplication
- Compositions And Methods Of Detecting And Treating Thrombosis And Vascular Plaquesapplication
- Compositions And Methods Of Detecting And Treating Alzheimer's Diseaseapplication
- Nanocomposites For Imaging And Drug Deliveryapplication
- Compositions And Methods Of Detecting And Treating Thrombosis And Vascular Plaquesapplication
- Alkylated Nucleosides, And Compositions And Methods Thereof For Nucleic Acid Deliveryapplication
- Methods And Compositions For Treatment Of Vascular Obstructionapplication
- Compositions And Methods Of Detecting And Treating Thrombosis And Vascular Plaquesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.